The merger, 16 months in the planning process, has been called off in a mutual agreement between the two companies.
At the end of July 2023, multistate cannabis companies Cresco Labs and Columbia Care announced that there would be no $2 billion merger, which had been first announced in March of 2022 (1). The merger was originally predicted to be one of the largest in the industry (2). Finalizations of the agreement were delayed once in March 2023 and again in June 2023 before being called off completely (3).
“In light of the evolving landscape in the cannabis industry, we believe the decision to terminate the planned transaction is in the long-term interest of Cresco Labs and our shareholders,” Cresco Labs CEO Charles Bachtell said in a press release (1).
In November of 2022, the companies also announced that nine dispensaries and three production facilities in three different states would be sold to entrepreneur and hip-hop mogul Sean “Diddy” Combs in order to fulfill state requirements that certain assets must be sold before the merger could continue (4). That agreement, said to be worth $185 million, has also been terminated (1). It would have created “the first minority-owned and operated, vertically integrated multistate operator,” according to both companies (4).
Cresco Labs and Columbia Care published the same press release on their websites concerning the terminated merger (1). A press release from Columbia Care dated July 31, 2023, also explained the company’s recent accomplishments and plans to move forward (5).
“With the uncertainty of the past 16 months behind us, along with the enthusiasm and energy that accompanies moments of renewal, our team welcomes the next stage of Columbia Care’s growth and expansion,” Nicholas Vita, CEO of Columbia Care said in the press release (5). “In spite of the challenges we have faced, the team has remained committed to the success of our Company and, as is obvious from the pace of activity, has been engaged at all levels, actively preparing for the future.”
Columbia Care is based in New York and Cresco Labs is headquartered in Chicago (3).
References
Ep 27: Tracking Strains in Diverse Landscapes
July 2nd 2025In this latest installment of Noid Knowledge, we are joined by Daniela Vergara, PhD, Hemp Specialist at the Cornell Cooperative Extension, and Anna Schwabe, PhD, Associate Lecture Professor at the University of Colorado, discussing the evolution of cannabis cultivation and the need for regional climate data. Their recent project, funded by the Agricultural Genomics Foundation, studies 10 cannabis varieties grown by farmers in different regions, specifically plant characteristics, soil type, and harvest metrics. They aim to understand how environmental factors affect cannabis yield and quality, providing actionable insights for farmers and breeders.
Best of the Week: July 4 – July 10, 2025
July 11th 2025Here, we bring you our top five recent articles covering revoking medical cannabis cards in Florida, testing and sampling initiative in Missouri, our mid-year regulations roundup, depenalization ordinance stopped in Texas, and accuracy in THC labeling in flower versus concentrates.
Ep 26: Innovations in Drying and Curing to Protect Flower Quality
May 27th 2025In this latest installment of Noid Knowledge, we are joined by Dr. Allison Justice, Founder and CEO of the Hemp Mine, and David Sandelman COO, CTO & Co-Founder of Cannatrol. Here, Allison and David discuss innovations in cannabis drying and curing, focusing on the Cannatrol technology which controls vapor pressure, preserving trichome integrity, and flower quality. Additionally, Allison shares how the Cannabis Research Center and Coalition (CRC) is transition to an open-source model to support cultivators, researchers, and home growers.